Quality of Life in Patients Treated with Sirolimus and Tacrolimus for Prevention of Graft-Versus-Host Disease

MLA

Claudio Anasetti, et al. “Quality of Life in Patients Treated with Sirolimus and Tacrolimus for Prevention of Graft-Versus-Host Disease.” Biology of Blood and Marrow Transplantation, vol. 19, no. 2, Feb. 2013, pp. S151–52. EBSCOhost, https://doi.org/10.1016/j.bbmt.2012.11.106.

APA

Claudio Anasetti, Anna Barata-Bardiella, Paul B. Jacobsen, Heather S. L. Jim, Brent J. Small, & Joseph Pidala. (2013). Quality of Life in Patients Treated with Sirolimus and Tacrolimus for Prevention of Graft-Versus-Host Disease. Biology of Blood and Marrow Transplantation, 19(2), S151–S152. https://doi.org/10.1016/j.bbmt.2012.11.106

Chicago

Claudio Anasetti, Anna Barata-Bardiella, Paul B. Jacobsen, Heather S. L. Jim, Brent J. Small, and Joseph Pidala. 2013. “Quality of Life in Patients Treated with Sirolimus and Tacrolimus for Prevention of Graft-Versus-Host Disease.” Biology of Blood and Marrow Transplantation 19 (2): S151–52. doi:10.1016/j.bbmt.2012.11.106.